Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database

BackgroundWith the widespread use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in managing diabetes and obesity, the occurrence of GLP-1 RA-induced cholecystitis and cholelithiasis has raised increasing concern among healthcare professionals.MethodsThis study extracted adverse event repo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chao Tao, Yinhui Zhang, Tenggang Wan, Wenting Zhao, Jing Chen, Ke Wang, Liuxuan Yang, Guojun Wang, Qian Ding, Jinlu Shang, Meiling Zhou
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-07-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	glucagon-like peptide-1 receptor agonists cholecystitis cholelithiasis disproportionality analysis pharmacovigilance FAERS
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1557691/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!